CORD-19:c654596857bce9cdd64ffc51842048643107348c / 285575-285744 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/c654596857bce9cdd64ffc51842048643107348c","sourcedb":"CORD-19","sourceid":"c654596857bce9cdd64ffc51842048643107348c","text":"We report the in-vitro activity of this compound in combination with ceftazidime, cefsulodin, fosfomycin, piperacillin/tazobactam, aztreonam, ciprofloxacin and timentin.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T2437","span":{"begin":0,"end":169},"obj":"Sentence"},{"id":"T63347","span":{"begin":0,"end":169},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T2437","pred":"source","obj":"CORD-19-Sentences"},{"subj":"T63347","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T358","span":{"begin":0,"end":169},"obj":"Sentence"}],"attributes":[{"subj":"T358","pred":"source","obj":"CORD-19_Custom_license_subset"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#ca93ec","default":true},{"id":"CORD-19_Custom_license_subset","color":"#93ecb0"}]}]}}